AAAAAA

   
Results: 1-11 |
Results: 11

Authors: VISONNEAU S CESANO A TRAN T JEGLUM KA SANTOLI D
Citation: S. Visonneau et al., SUCCESSFUL TREATMENT OF CANINE MALIGNANT HISTIOCYTOSIS WITH THE HUMANMAJOR HISTOCOMPATIBILITY COMPLEX NONRESTRICTED CYTOTOXIC T-CELL LINE TALL-104, Clinical cancer research, 3(10), 1997, pp. 1789-1797

Authors: CESANO A VISONNEAU S WOLFE JH JEGLUM KA FERNANDEZ J GILLIO A OREILLY RJ SANTOLI D
Citation: A. Cesano et al., TOXICOLOGICAL AND IMMUNOLOGICAL EVALUATION OF THE MHC-NON-RESTRICTED CYTOTOXIC T-CELL LINE TALL-104, Cancer immunology and immunotherapy, 44(3), 1997, pp. 125-136

Authors: ROSENTHAL RC JEGLUM KA
Citation: Rc. Rosenthal et Ka. Jeglum, CONTROVERSIES IN CLINICAL ONCOLOGY - PREFACE, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 11-12

Authors: JEGLUM KA
Citation: Ka. Jeglum, CHEMOIMMUNOTHERAPY OF CANINE LYMPHOMA WITH ADJUVANT CANINE MONOCLONAL-ANTIBODY-231, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 73

Authors: JEGLUM KA SADANAGA K
Citation: Ka. Jeglum et K. Sadanaga, ORAL TUMORS - THE SURGEON AND THE MEDICAL ONCOLOGIST, The Veterinary clinics of North America. Small animal practice, 26(1), 1996, pp. 145

Authors: CESANO A VISONNEAU S JEGLUM KA OWEN J WILKINSON K CARNER K REESE L SANTOLI D
Citation: A. Cesano et al., PHASE-I CLINICAL-TRIAL WITH A HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX NONRESTRICTED CYTOTOXIC T-CELL LINE (TALL-104) IN DOGS WITH ADVANCED TUMORS, Cancer research, 56(13), 1996, pp. 3021-3029

Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HEIFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY (VOL 10, PG 125, 1995), Cancer biotherapy, 10(3), 1995, pp. 249-249

Authors: FOX LE MACEWEN EG KURZMAN ID DUBIELZIG RR HELFAND SC VAIL DM KISSEBERTH W LONDON C MADEWELL BR RODRIGUEZ CO JEGLUM KA ROSENBERG M ROSENTHAL RC
Citation: Le. Fox et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE FORTHE TREATMENT OF FELINE MAMMARY ADENOCARCINOMA - A MULTICENTER RANDOMIZED DOUBLE-BLIND-STUDY, Cancer biotherapy, 10(2), 1995, pp. 125-130

Authors: HELFAND SC HAMILTON TA HUNGERFORD LL JEGLUM KA GOLDSCHMIDT MA
Citation: Sc. Helfand et al., COMPARISON OF 3 TREATMENTS FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER IN THE DOG, The Journal of the American Animal Hospital Association, 30(3), 1994, pp. 270-275

Authors: KILRAIN CG SAIK JE JEGLUM KA
Citation: Cg. Kilrain et al., MALIGNANT ANGIOENDOTHELIOMATOSIS WITH RETINAL DETACHMENTS IN A DOG, Journal of the American Veterinary Medical Association, 204(6), 1994, pp. 918-921

Authors: SORENMO KU JEGLUM KA HELFAND SC
Citation: Ku. Sorenmo et al., CHEMOTHERAPY OF CANINE HEMANGIOSARCOMA WITH DOXORUBICIN AND CYCLOPHOSPHAMIDE, Journal of veterinary internal medicine, 7(6), 1993, pp. 370-376
Risultati: 1-11 |